Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Sankt Gallen
Clinical trial register · Switzerland

Clinical Trials in Sankt Gallen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Switzerland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2249 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2249
Studies in scope
all four open statuses
1364
Recruiting now
open to new participants
528
Lead sponsors
across recruiting studies
Top sites
Zurich 739 Bern 722 Basel 636 Geneva 406 Lausanne 394
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Basel, Switzerland17 Merck Sharp & Dohme LLC15 Amgen12 Insel Gruppe AG, University Hospital Bern11 Bristol-Myers Squibb10 Swiss Cancer Institute10 Janssen Research & Development, LLC9 AbbVie7 Cantonal Hospital of St. Gallen5 University of Bern5 AstraZeneca5 Daiichi Sankyo4 Incyte Corporation4 Novartis Pharmaceuticals4 CatalYm GmbH4 ETOP IBCSG Partners Foundation4 Novo Nordisk A/S4 Eli Lilly and Company3 Akero Therapeutics, Inc3 European Myeloma Network B.V.3 Biogen3 European Organisation for Research and Treatment of Cancer - EORTC3 University of Zurich3 Boehringer Ingelheim3 University Children's Hospital Basel3 Show all 122
Site location
Zurich739 Bern722 Basel636 Geneva406 Lausanne394 Sankt Gallen272 Lucerne152 Bellinzona148 Aarau136 Lugano131 Chur99 Baden81 Winterthur81 Fribourg72 Liestal35 Olten32 Sion24 Frauenfeld22 Thun19 Münsterlingen15 Nottwil15 Biel14 Neuchâtel13 Solothurn12 Meyrin12 Show all 151
All 151 locations
Target enrolment
to

Trials with a site in Sankt Gallen

272 of 2249 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Switzerland
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Basel, Bern, Lucerne, Sankt Gallen, Zurich
2027-11-23
Not yet open
InnoMedica Schweiz AG
Phase 2
40
Aarau, Geneva, Sankt Gallen, Lausanne, Zurich, Konolfingen
2027-01
Not yet open
Flow-Controlled Ventilation to Improve Postoperative Pulmonary Outcome After Thoracic Surgery
NCT07623395Mechanical Ventilation, Postoperative Pulmonary Complications (PPCs)
Cantonal Hospital of St. Gallen
Not applicable
140
Sankt Gallen, Basel, Zurich
2026-12-01
Not yet open
University Hospital, Basel, Switzerland
Phase 2
66
Basel, Biel/Bienne, Sankt Gallen, Zurich, Bellinzona
2026-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2
480
Sankt Gallen, Lausanne
2026-10-21
Recruiting
Swiss Cancer Institute
Phase 2
108
Fribourg, Basel, Bellinzona, Bern, Geneva, Lausanne, Münsterlingen, Sankt Gallen
2026-10-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
200
Bellinzona, Sankt Gallen
2026-10-07
Recruiting
Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07149649Metastatic NSCLC - Non-Small Cell Lung Cancer
Swiss Cancer Institute
Phase 2/3
230
Aarau, Baden, Basel, Chur, Lucerne, Olten, Sankt Gallen, Winterthur
2026-09-29
Recruiting
Swiss Cancer Institute
Phase 2
92
Aarau, Basel, Bellinzona, Bern, Chur, Geneva, Lucerne, Sankt Gallen
2026-09-24
Recruiting
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
NCT06804655Brain (Nervous System) Cancers, Glioblastoma, Glioma, Ependymoma
University of Zurich
Phase 2
40
Basel, Sankt Gallen, Zurich
2026-09-11
Recruiting
Incyte Corporation
Phase 3
426
Bern, Sankt Gallen, Tellstrasse, Zurich
2026-09-08
Recruiting
Swiss Cancer Institute
Phase 2
47
Baden, Basel, Chur, Fribourg, Geneva, Sankt Gallen, Thun, Winterthur
2026-08-21
Recruiting
NEST: A Group Intervention for Parents With Complex PTSD
NCT07766265Complex Post-Traumatic Stress Disorder
St.Gallen University of Applied Sciences
Not applicable
32
Windisch, Sankt Gallen, Winterthur
2026-08-01
Not yet open
University Hospital, Basel, Switzerland
Not applicable
270
Basel, Bern, Lausanne, Sankt Gallen, Zurich
2026-08
Recruiting
Boehringer Ingelheim
Phase 3
448
Sankt Gallen
2026-07-27
Active, closed
AI Ambient Scribe in Psychiatry
NCT07777224Therapeutic Alliance, Empathy, Documentation, Artificial Intelligence (AI)
Psychiatrie St. Gallen
Not applicable
47
Heerbrugg, Pfäfers Dorf, Rorschach, Sankt Gallen, Sargans, Uznach, Wattwil, Wil
2026-07-13
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Basel, Sankt Gallen, Lugano, Geneva, Lucerne
2026-06-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1
120
Sankt Gallen, Lausanne, Bellinzona
2026-06-18
Not yet open
Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery
NCT07180615Surgical Site Infection, Colon Surgery, Surgical Site Infections
DrugsRifaximin·Metronidazole
Universität Luzern
Phase 4
458
Aarau, Lucerne, Sankt Gallen, Zurich
2026-06-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
170
Aarau, Baden, Basel, Bern, Geneva, Sankt Gallen, Zurich
2026-06-01
Recruiting
Amgen
Phase 1
160
Sankt Gallen
2026-04-21
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugVisugromab
CatalYm GmbH
Phase 2/3
518
Aarau, Basel, Bellinzona, Lugano, Sankt Gallen, Zurich
2026-04-16
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
48
Baden, Fribourg, Geneva, Sankt Gallen
2026-04-15
Recruiting
Bristol-Myers Squibb
Phase 1/2
474
Chur, Sankt Gallen, Zurich
2026-03-26
Recruiting
Bristol-Myers Squibb
Phase 3
850
Basel, Bellinzona, Münsterlingen, Sankt Gallen
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Lausanne, Sankt Gallen, Thun, Villars-sur-Glâne
2026-03-12
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
DrugEnpatoran
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Basel, Sankt Gallen
2026-03-10
Recruiting
Incyte Corporation
Phase 3
700
Bern, Lausanne, Sankt Gallen
2026-03-05
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Basel, Bern, Fribourg, Geneva, Sankt Gallen, Zurich
2026-03-01
Recruiting
Galderma R&D
Phase 2
162
Sankt Gallen
2026-02-20
Recruiting
University Hospital, Basel, Switzerland
Phase 2/3
152
Basel, Geneva, Sankt Gallen
2026-02-16
Recruiting
Targeting Real World Usage In Stroke Treatment
NCT07474935Saccular and Fusiform Aneurysms, Pseudoaneurysm, Vascular Dissection, Perforation
Phenox GmbH
Observational
5,000
Basel, Sankt Gallen
2026-01-29
Recruiting
Janssen Research & Development, LLC
Phase 3
115
Sankt Gallen
2026-01-05
Recruiting
AstraZeneca
Phase 3
1,100
Basel, Münsterlingen, Sankt Gallen, Thun, Zollikerberg, Zurich
2025-12-29
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Basel, Sankt Gallen
2025-12-23
Recruiting
Charlotte Vogt
Not applicable
38
Sankt Gallen
2025-12-16
Recruiting
Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Adolescents - A Validation Study in Switzerland and Germany
NCT07368166PTSD - Post Traumatic Stress Disorder, PTSD-Related Functional Impairment in Children and Adolescents
University Children's Hospital, Zurich
Observational
1,200
Frauenfeld, Sankt Gallen, Winterthur, Zurich
2025-12-15
Recruiting
Reminder Strategies to Improve Meal-Logging Adherence
NCT07555262Patient Compliance, Mobile Applications, Reminder Systems
University of St.Gallen
Not applicable
200
Sankt Gallen
2025-12-08
Recruiting
University of St.Gallen
Observational
200
Sankt Gallen
2025-12-08
Recruiting
University Hospital, Basel, Switzerland
Not applicable
18,000
Basel, Lausanne, Aarau, Baden, Geneva, Lucerne, Lugano, Sankt Gallen
2025-12-03
Not yet open
University of Zurich
Phase 2
98
Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2025-12-01
Recruiting
Amgen
Phase 3
750
Bern, Lausanne, Sankt Gallen, Zurich
2025-11-28
Recruiting
Hoffmann-La Roche
Phase 3
250
Bern, Olten, Sankt Gallen
2025-11-27
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Baden, Sankt Gallen, Bellinzona
2025-11-05
Recruiting
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT06888193Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, Hidradenitis Suppurativa
DrugBimekizumab
UCB Biopharma SRL
Phase 1
20
Lausanne, Sankt Gallen
2025-11-05
Recruiting
Swiss Cancer Institute
Phase 2
24
Aarau, Basel, Bellinzona, Bern, Lausanne, Sankt Gallen, Winterthur, Zurich
2025-10-27
Recruiting
Novo Nordisk A/S
Phase 1
30
Sankt Gallen
2025-10-23
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Bern, Sankt Gallen, Bellinzona, Geneva
2025-10-23
Recruiting
Fiber-Boost Randomized Controlled Trial
NCT07483112Non-Small Cell Carcinoma of Lung
Cantonal Hospital of St. Gallen
Not applicable
42
Basel, Chur, Sankt Gallen, Winterthur
2025-10-07
Recruiting
Amgen
Phase 1
60
Chur, Lausanne, Sankt Gallen
2025-10-07
Recruiting
CatalYm GmbH
Phase 2
131
Basel, Sankt Gallen
2025-10-07
Recruiting
Linezolid Plus Standard of Care
NCT06958835Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
DrugLinezolid
University Hospital, Basel, Switzerland
Not applicable
606
Aarau, Basel, Bern, Geneva, Delémont, Sankt Gallen, Lausanne, Winterthur
2025-10-06
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bern, Sankt Gallen
2025-10-03
Active, closed
Fabiën Belle
Observational
12,150
Aarau, Basel, Bern, Geneva, Lucerne, Sankt Gallen, Zurich, Bellinzona
2025-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bern, Sankt Gallen, Zurich
2025-10-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Sankt Gallen, Bellinzona, Chur, Zurich
2025-09-30
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Aarau, Basel, Geneva, Neuchâtel, Sankt Gallen, Zurich
2025-09-13
Recruiting
Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases
NCT06620380Brain Metastases, Brain Metastases, Adult
University of Zurich
Phase 2
102
Basel, Sankt Gallen, Zurich
2025-09-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Sankt Gallen, Lausanne, Zurich
2025-09-11
Recruiting
Prospective Evaluation of OptiThyDose
NCT06864351Thyroid Diseases, Congenital Hypothyroidism, Graves Disease
University Children's Hospital Basel
Not applicable
150
Basel, Lausanne, Lucerne, Sankt Gallen, Zurich
2025-08-28
Recruiting
Eastern Switzerland University of Applied Sciences
Observational
52
Sankt Gallen
2025-08-28
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 3
172
Geneva, Sankt Gallen, Zurich
2025-08-27
Recruiting
Distalmotion SA
Observational
33
Interlaken, Langenthal, Sankt Gallen
2025-08-05
Recruiting
PROtective Ventilation With FLOW-Controlled Ventilation
NCT06703814Postoperative Pulmonary Complications (PPCs), Feasibility Studies, Pilot Study
Cantonal Hospital of St. Gallen
Not applicable
100
Sankt Gallen
2025-08-02
Recruiting
CatalYm GmbH
Phase 2
107
Basel, Fribourg, Sankt Gallen
2025-08-01
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Basel, Lausanne, Lucerne, Lugano, Sankt Gallen, Zurich
2025-07-22
Recruiting
Swiss Cancer Institute
Phase 2
50
Sankt Gallen, Genolier, Winterthur, Chur, Aarau, Lausanne
2025-07-16
Recruiting
University Children's Hospital Basel
Not applicable
750
Aarau, Basel, Bern, Chur, Geneva, Lausanne, Lucerne, Sankt Gallen
2025-07-12
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Basel, Bern, Geneva, Lucerne, Sankt Gallen
2025-07-02
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen
2025-06-25
Active, closed
AbbVie
Phase 3
573
Lucerne, Sankt Gallen, Bern
2025-06-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
110
Aarau, Basel, Bern, Lucerne, Lugano, Sankt Gallen
2025-06-01
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Basel, Bern, Sankt Gallen
2025-05-27
Recruiting
Swiss Cancer Institute
Observational
30
Aarau, Baden, Basel, Bern, Biel, Chur, Lucerne, Sankt Gallen
2025-05-25
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Basel, Fribourg, Sankt Gallen
2025-05-06
By invitation
Novo Nordisk A/S
Observational
1,250
Bern, Geneva, Lucerne, Lugano, Neuchâtel, Olten, Sankt Gallen, Zurich
2025-05-01
Recruiting
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
NCT06279000Cardiovascular Diseases, Cardiovascular Complication, Perioperative Complication, Myocardial Injury
DrugColchicine
Cantonal Hospital of St. Gallen
Phase 3
880
Sankt Gallen
2025-04-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
605
Basel, Lausanne, Sankt Gallen
2025-04-15
Recruiting
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NCT06466382Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Ovarian Endometrioid Carcinoma, High-grade Serous Ovarian Carcinoma (HGSOC)
Swiss GO Trial Group
Not applicable
60
Baden, Basel, Sankt Gallen, Frauenfeld, Aarau, Bern, Fribourg, Lucerne
2025-03-31
Recruiting
AstraZeneca
Phase 3
600
Frauenfeld, Liestal, Sankt Gallen, Zurich
2025-03-27
Active, closed
Amgen
Phase 3
3,853
Basel, Geneva, Sankt Gallen, Zurich
2025-03-12
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Bern, Sankt Gallen
2025-03-12
Recruiting
University Hospital, Basel, Switzerland
Not applicable
972
Basel, Bern, Sankt Gallen, Lausanne, Zurich, Aarau, Geneva
2025-02-20
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
NCT06823466Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF), Outcome Assessment
University of L'Aquila
Observational
200
Sankt Gallen
2025-02-12
Recruiting
A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
NCT06325293Community Acquired Pneumonia in Children, Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia
Christoph Berger
Not applicable
376
Aarau, Basel, Bern, Fribourg, Geneva, Lucerne, Sankt Gallen, Lausanne
2025-01-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Baden, Sankt Gallen, Bellinzona, Lugano
2025-01-27
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Baden, Basel, Bellinzona, Bern, Fribourg, Lausanne, Sankt Gallen, Winterthur
2025-01-15
Active, closed
Amgen
Phase 2
61
Basel, Geneva, Sankt Gallen
2024-12-26
Active, closed
Amgen
Phase 3
707
Bellinzona, Bern, Chur, Lausanne, Sankt Gallen
2024-12-09
Recruiting
"Bliib Fit - Mach Mit!" in Residential Care Facilities
NCT06738186Physical Fitness in Older Adults, Exercise Program
Eastern Switzerland University of Applied Sciences
Not applicable
40
Sankt Gallen
2024-12-05
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Basel, Sankt Gallen
2024-12-04
Active, closed
argenx
Phase 2
87
Sankt Gallen, Zurich
2024-11-11
Recruiting
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
NCT06358573Triple-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer
DrugINT230-6
Swiss Cancer Institute
Phase 2
61
Aarau, Basel, Bellinzona, Chur, Liestal, Sankt Gallen, Winterthur, Zurich
2024-10-24
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Basel, Sankt Gallen
2024-10-17
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Olten, Lugano, Bern, Sankt Gallen, Zurich
2024-10-04
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Aarau, Baden, Liestal, Basel, Sankt Gallen, Lausanne, Winterthur, Zurich
2024-09-27
Recruiting
Registry for Automated Mechanical VEntilation in Adults
NCT06655805Respiratory Insufficiency Requiring Mechanical Ventilation
Hamilton Medical AG
Observational
1,000
Sankt Gallen, Chur, Winterthur
2024-09-23
Active, closed
OncoVerity, Inc.
Phase 2
140
Bern, Fribourg, Sankt Gallen
2024-07-22
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Sankt Gallen
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Basel Town, Buochs, Sankt Gallen, Zurich
2024-06-27
Active, closed
Genmab
Phase 3
621
Bellinzona, Geneva, Lausanne, Sankt Gallen
2024-06-25
Recruiting
University Hospital, Basel, Switzerland
Phase 4
100
Baden, Basel, Liestal, Sankt Gallen
2024-06-24
Active, closed
Amgen
Phase 3
563
Basel, Bern, Mendrisio, Sankt Gallen
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Basel, Bern, Sankt Gallen, Zurich
2024-06-05
Recruiting
SASL Swiss Cirrhosis Cohort
NCT06092385Liver Cirrhosis
University Hospital, Basel, Switzerland
Observational
3,000
Lugano, Basel, Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2024-06-04
Recruiting
PENTA Foundation
Not applicable
3,080
Basel, Bern, Geneva, Sankt Gallen, Zurich
2024-05-28
Recruiting
Daiichi Sankyo
Phase 3
540
Bern, Sankt Gallen, Villars-sur-Glâne
2024-05-21
Active, closed
Alnylam Pharmaceuticals
Phase 2
210
Bern, Geneva, Sankt Gallen
2024-05-17
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Baden, Basel, Bern, Lucerne, Lugano, Sankt Gallen, Winterthur, Zurich
2024-05-15
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Lugano, Lausanne, Basel, Bern, Geneva, Lucerne, Sankt Gallen, Zurich
2024-05-01
Recruiting
Restorative Environments for Gait Therapy with VR
NCT06304077Gait Analysis, Virtual Reality, Attention, Stress
ETH Zurich
Not applicable
84
Schaffhausen, Sankt Gallen, Zollikerberg
2024-04-23
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
300
Basel, Bellinzona, Geneva, Sankt Gallen, Zurich
2024-04-11
Recruiting
Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood
NCT06486909Aneurysm, Ruptured, Hyperglycemia, Hydrocephalus
Isabel Hostettler
Observational
160
Aarau, Basel, Sankt Gallen
2024-03-26
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,182
Basel, Bern, Lucerne, Sankt Gallen, Zurich
2024-01-11
Recruiting
University Hospital, Basel, Switzerland
Not applicable
200
Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen, Sion
2024-01-01
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
44
Baden, Basel, Bern, Sankt Gallen, Sion, Solothurn, Winterthur
2023-12-20
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Baden, Sankt Gallen, Winterthur, Basel, Bern
2023-12-12
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Olten, Bern, Sankt Gallen
2023-12-01
Active, closed
The PIFPAF-PFA Study
NCT05986526Persistent Atrial Fibrillation
Insel Gruppe AG, University Hospital Bern
Not applicable
206
Baden, Basel, Bern, Lausanne, Sankt Gallen, Zurich
2023-11-13
By invitation
B-free Multistage Trial
NCT06037564HIV, Drug Resistance, Drug Drug Interaction
Insel Gruppe AG, University Hospital Bern
Phase 4
210
Aarau, Basel, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-11-13
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Olten, Bern, Sankt Gallen
2023-11-10
Active, closed
AstraZeneca
Phase 3
863
Baden, Basel, Bern, Fribourg, Sankt Gallen
2023-11-09
Recruiting
Institut Curie
Not applicable
600
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2023-11-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Bern, Sankt Gallen, Zurich
2023-10-25
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Baden, Frauenfeld, Fribourg, Geneva, La Chaux-de-Fonds, Lausanne, Liestal, Sankt Gallen
2023-10-24
By invitation
Biogen
Phase 3
306
Lausanne, Sankt Gallen
2023-10-03
Recruiting
Abbott Medical Devices
Observational
1,000
Sankt Gallen
2023-09-29
Active, closed
Bristol-Myers Squibb
Phase 3
774
Bern, Sankt Gallen
2023-09-11
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Baden, Bern, Sankt Gallen, Villars-sur-Glâne
2023-09-07
Active, closed
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU
Helsinki University Central Hospital
Not applicable
3,500
Bern, Sankt Gallen, Zurich
2023-08-17
Active, closed
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain
Region Skane
Not applicable
3,500
Bern, Sankt Gallen, Zurich
2023-08-17
Recruiting
Stepcare Extended Follow-up Substudy
NCT06207942Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain, Cognitive Impairment, Caregiver Burden
Region Skane
Not applicable
600
Bern, Sankt Gallen
2023-08-01
Active, closed
AbbVie
Phase 3
1,014
Basel Town, Sankt Gallen, Bern
2023-07-25
Recruiting
Incyte Corporation
Phase 1
570
Bellinzona, Lausanne, Sankt Gallen
2023-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 1
95
Geneva, Sankt Gallen, Bellinzona
2023-07-06
Active, closed
AbbVie
Phase 3
1,328
Sankt Gallen, Zurich, Bern
2023-06-21
Recruiting
Cantonal Hospital of St. Gallen
Observational
400
Sankt Gallen
2023-06-12
Active, closed
AbbVie
Observational
1,019
Meyrin, Sankt Gallen, Lausanne, Zurich, Bern
2023-06-09
Active, closed
Amgen
Phase 3
509
Chur, Fribourg, Geneva, Sankt Gallen, Winterthur
2023-05-31
Recruiting
Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fracture
NCT05769114SPINAL Fracture, Burst Fracture, Spinal Instability of Thoracolumbar Region
Insel Gruppe AG, University Hospital Bern
Not applicable
52
Bern, Sankt Gallen
2023-04-18
Recruiting
University Hospital, Geneva
Observational
400
Bellinzona, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-04-01
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
60
Bellinzona, Bern, Geneva, Sankt Gallen
2023-03-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
641
Basel, Geneva, Sankt Gallen, Zurich, Lugano, Bern
2023-03-17
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Basel, Zurich, Sankt Gallen
2023-03-16
Recruiting
Benoit Guery
Phase 3
100
Basel, Bern, Fribourg, Lucerne, Sankt Gallen, Lausanne, Zurich, Sion
2023-03-15
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Aarau, Basel, Bern, Lausanne, Sankt Gallen
2023-02-15
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Bern, Lucerne, Sankt Gallen, Zurich
2023-02-13
Active, closed
University Hospital, Basel, Switzerland
Not applicable
920
Basel, Aarau, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-02-05
Active, closed
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
NCT05397106Hydrocephalus, Hydrocephalus in Children, NPH (Normal Pressure Hydrocephalus), IIH - Idiopathic Intracranial Hypertension
Integra LifeSciences Corporation
Observational
160
Sankt Gallen
2023-01-24
Active, closed
Daiichi Sankyo
Phase 3
1,233
Liestal, Sankt Gallen, Thun
2023-01-11
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Lausanne, Sankt Gallen
2022-12-21
Recruiting
Immunocore Ltd
Phase 3
540
Sankt Gallen, Zurich
2022-12-19
Recruiting
University Hospital, Basel, Switzerland
Observational
1,000
Aarau, Lucerne, Basel, Bern, Rothrist, Sankt Gallen, Zurich
2022-12-16
Active, closed
Calmy Alexandra
Phase 4
225
Basel, Bern, Geneva, Sankt Gallen, Lausanne, Zurich, Lugano
2022-12-14
Active, closed
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
NCT05688280Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer, Soft Tissue Sarcoma
DrugIP-001
Immunophotonics, Inc.
Phase 1/2
42
Bellinzona, Bern, Chur, Sankt Gallen
2022-11-29
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Sankt Gallen
2022-11-21
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Bern, La Chaux-de-Fonds, Sankt Gallen, Zurich
2022-10-27
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bern, Sankt Gallen
2022-10-25
Active, closed
Genmab
Phase 3
549
Aarau, Sankt Gallen, Bellinzona, Chur
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Basel, Bern, Sankt Gallen, Zurich
2022-09-19
Active, closed
Biogen
Phase 2/3
450
Zurich-Flughafen, Lausanne, Sankt Gallen
2022-09-13
Active, closed
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
NCT05399992Primary Hypercholesterolemia, Mixed Dyslipidemia
Novartis Pharmaceuticals
Observational
847
Fribourg, Basel, Geneva, Lausanne, Olten, Sankt Gallen, Zurich
2022-09-12
Active, closed
European Myeloma Network B.V.
Phase 3
1,594
Basel, Bern, Sankt Gallen
2022-09-08
Recruiting
AstraZeneca
Phase 2
454
Basel, Bellinzona, Sankt Gallen
2022-09-06
Active, closed
Biogen
Phase 2
416
Lugano, Biel/Bienne, Geneva, Sankt Gallen
2022-08-24
Recruiting
Susanne Rogers
Not applicable
200
Aarau, Bern, Chur, Lucerne, Sankt Gallen, Winterthur
2022-07-29
Active, closed
Gilead Sciences
Phase 3
443
Baden, Liestal, Sankt Gallen, Winterthur, Zurich
2022-07-25
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Basel, Bern, Sankt Gallen, Zurich
2022-07-22
Active, closed
Gilead Sciences
Phase 3
623
Sankt Gallen
2022-07-20
Recruiting
Z-Systems
Observational
240
Solothurn, Olten, Sankt Gallen
2022-07-01
Active, closed
Celgene
Phase 3
939
Chur, Sankt Gallen
2022-06-23
Recruiting
Swiss Society of Dermatology and Venereology
Observational
700
Basel, Bern, Buochs, Fribourg, Lausanne, Lucerne, Sankt Gallen, Uster
2022-06-02
Recruiting
Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
NCT04043598Subarachnoid Hemorrhage, Critical Illness, Infusion Fluid, Sodium Disorder
Insel Gruppe AG, University Hospital Bern
Not applicable
320
Sankt Gallen, Bern, Geneva
2022-05-24
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Basel, Bern, Lausanne, Sankt Gallen
2022-05-23
Active, closed
University Hospital, Basel, Switzerland
Observational
650
Basel, Bern, Sankt Gallen
2022-05-20
Recruiting
Prof. Wolfgang Janni
Phase 4
300
Brig, Sankt Gallen
2022-04-27
Recruiting
UNICANCER
Phase 3
300
Bellinzona, Chur, Sankt Gallen, Viganello, Zurich
2022-04-19
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL)
DrugBexobrutideg
Nurix Therapeutics, Inc.
Phase 1
572
Basel, Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
2022-04-13
Active, closed
DreaMS - Validation Study 1
NCT05009160Multiple Sclerosis
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Observational
300
Aarau, Lausanne, Lugano, Sankt Gallen, Zurich, Basel
2022-03-30
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Bern, Sankt Gallen, Geneva, Zurich
2022-03-29
Active, closed
Daiichi Sankyo
Phase 3
740
Baden, Basel, Liestal, Sankt Gallen
2022-03-04
Active, closed
Amgen
Phase 1/2
329
Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
2022-02-01
Active, closed
Mirror Medacta Shoulder System Pivotal Trial
NCT05062252Arthritis Shoulder, Post-traumatic Arthrosis of Other Joints, Upper Arm
Medacta International SA
Not applicable
100
Bern, Sankt Gallen
2022-01-05
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Sankt Gallen, Bellinzona
2021-12-17
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Chur, Sankt Gallen, Winterthur
2021-12-14
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Aarau, Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen
2021-12-09
Active, closed
Sanofi
Phase 2
109
Sankt Gallen
2021-11-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Basel, Geneva, Sankt Gallen, Zurich, Lugano, Bern
2021-09-15
Active, closed
Bristol-Myers Squibb
Phase 3
338
Basel, Sankt Gallen
2021-09-15
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Zurich, Aarau, Baden, Basel, Bern, Chur, Lucerne, Sankt Gallen
2021-08-27
Recruiting
Clinical Validation of BoneMRI in the Spine
NCT06745791Bone Diseases, Image, Medical Device
MRIguidance B.V.
Observational
450
Sankt Gallen
2021-08-20
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
110
Sankt Gallen
2021-08-19
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Basel, Bern, Sankt Gallen
2021-08-19
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Basel, Bern, Lugano, Sankt Gallen
2021-08-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
89
Sankt Gallen
2021-06-14
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Basel, Bern, Fribourg, Geneva, Sankt Gallen, Zurich
2021-05-15
Active, closed
Incyte Corporation
Phase 3
654
Basel, Bellinzona, Bern, Sankt Gallen, Winterthur, Zurich
2021-04-15
Active, closed
Eli Lilly and Company
Phase 3
101
Basel, Sankt Gallen
2021-04-13
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Bern, Geneva, Olten, Sankt Gallen, Zurich
2021-04-01
Active, closed
Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study
NCT04881578Cryptogenic Stroke, Foramen Ovale, Patent, Atrial Fibrillation
Raban Jeger
Observational
200
Zurich, Basel, Bern, Sankt Gallen, Solothurn
2021-03-31
Recruiting
Giulia Manzini
Phase 3
210
Aarau, Basel, Lucerne, Lugano, Sankt Gallen
2021-03-25
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Sankt Gallen
2021-02-23
Active, closed
Galderma R&D
Phase 3
500
Bern, Buochs, Lausanne, Obbürgen, Sankt Gallen, Weinfelden
2021-01-11
Recruiting
Dr. med. Gautier Müllhaupt
Not applicable
120
Sankt Gallen
2021-01-05
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Basel, Bern, Sankt Gallen
2020-12-22
Active, closed
Daiichi Sankyo
Phase 3
605
Bern, Sankt Gallen, Zurich
2020-12-21
Active, closed
CatalYm GmbH
Phase 1/2
199
Basel, Sankt Gallen, Zurich
2020-12-09
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Sankt Gallen, Villars-sur-Glâne
2020-12-02
Recruiting
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
NCT04588311Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries
DrugEpoetin Alfa
Australian and New Zealand Intensive Care Research Centre
Phase 3
2,500
Bern, Lucerne, Sankt Gallen
2020-11-09
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Chur, Sankt Gallen, Zurich
2020-10-28
Recruiting
University of Birmingham
Phase 1/2
1,672
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2020-09-17
Recruiting
Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions
NCT04449523Silent Stroke, Silent Cerebral Infarct, Fibrillation
Insel Gruppe AG, University Hospital Bern
Observational
150
Lausanne, Aarau, Basel, Bern, Sankt Gallen, Zurich
2020-09-08
Active, closed
Swiss Cancer Institute
Phase 2
90
Aarau, Baden, Basel, Bellinzona, Bern, Chur, Geneva, Sankt Gallen
2020-07-15
Active, closed
Eli Lilly and Company
Phase 3
996
Bern, Sankt Gallen
2020-06-22
Recruiting
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases
DrugRivaroxaban
Drahomir Aujesky
Phase 4
276
Liestal, Aarau, Bern, Biel/Bienne, Fribourg, Lucerne, Olten, Sankt Gallen
2020-05-15
Recruiting
Restrictive Use of Dexamethasone in Glioblastoma
NCT04266977Glioblastoma, Dexamethasone, Steroids
DrugDexamethasone
Insel Gruppe AG, University Hospital Bern
Not applicable
50
Sankt Gallen, Basel, Bern, Zurich
2020-05-08
Recruiting
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis, Multiple Sclerosis
University of Bern
Observational
500
Aarau, Sankt Gallen, Lausanne, Winterthur, Bellinzona, Chur, Basel, Bern
2020-04-14
Recruiting
Amgen
Phase 1
479
Bellinzona, Chur, Lausanne, Sankt Gallen
2020-03-04
Active, closed
OncoVerity, Inc.
Phase 1
61
Bern, Sankt Gallen
2019-12-23
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2019-11-05
Recruiting
University Hospital Muenster
Phase 3
683
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2019-08-23
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Basel, Sankt Gallen, Zurich
2019-08-09
Active, closed
Swiss Cancer Institute
Phase 2
135
Basel, Bellinzona, Bern, Chur, Lausanne, Sankt Gallen, Sion, Winterthur
2019-07-29
Recruiting
Population Health Research Institute
Phase 4
2,270
Basel, Sankt Gallen, Winterthur
2019-06-14
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,210
Aarau, Baden, Bellinzona, Bruderholz, Chur, Münsterlingen, Sankt Gallen, Zurich
2019-06-06
Recruiting
Swiss Severe Asthma Register
NCT03984253Severe Asthma
Prof. Dr. Jörg Leuppi
Observational
600
Liestal, Bern, Chur, Davos, Geneva, Lausanne, Lugano, Sankt Gallen
2019-05-13
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Basel, Bellinzona, Bern, Fribourg, Geneva, Lucerne, Sankt Gallen, Zurich
2019-03-01
Active, closed
Stichting European Myeloma Network
Phase 3
709
Sankt Gallen
2018-12-14
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
DrugDaromun
Philogen S.p.A.
Phase 3
186
Basel, Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
2018-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Basel, Bern, Geneva, Sankt Gallen, Lausanne, Zurich, Bellinzona, Chur
2018-09-12
Active, closed
Norwegian University of Science and Technology
Phase 2
212
Basel, Bern, Chur, Olten, Sankt Gallen, Thun, Winterthur, Zurich
2018-07-31
Active, closed
Eli Lilly and Company
Phase 3
1,058
Bern, Sankt Gallen, Zurich
2018-07-18
Active, closed
University of Bern
Not applicable
1,246
Lausanne, Bern, Geneva, Sankt Gallen, Zurich
2018-07-16
Recruiting
Martin Schrappe
Phase 3
5,000
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2018-07-15
Active, closed
Clinical and Radiological Outcomes of Medacta Shoulder System
NCT03547947Primary Osteoarthritis, Secondary Osteoarthritis, Rotator Cuff Tear Arthropathy, Rheumatoid Arthritis Shoulder
Medacta International SA
Observational
200
Bern, Sankt Gallen
2018-06-13
Active, closed
Exelixis
Phase 3
837
Basel, Bern, Sankt Gallen, Zurich
2018-06-10
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Basel, Bern, Geneva, Sankt Gallen, Zurich
2018-04-27
Recruiting
Post-Market BTVA Registry
NCT03318406Emphysema or COPD
Uptake Medical Technology, Inc.
Observational
300
Aarau, Basel, Bern, Sankt Gallen, Zurich
2018-03-22
Recruiting
Alain Kaelin
Phase 3
48
Bern, Lausanne, Lugano, Sankt Gallen, Zurich
2018-02-21
Recruiting
Cardiac Dysfunction in Childhood Cancer Survivors
NCT03790943Cardiac Dysfunction, Cardiovascular Diseases, Childhood Cancer
University of Bern
Observational
500
Basel, Bern, Geneva, Lucerne, Sankt Gallen
2018-02-13
Active, closed
AMPLATZER PFO Occluder Post Approval Study
NCT03309332Stroke, Patent Foramen Ovale
Abbott Medical Devices
Not applicable
1,214
Sankt Gallen
2018-01-31
Active, closed
Thurgau Breast Center
Observational
515
Aarau, Baden, Bern, Chêne-Bougeries, Sankt Gallen, Wetzikon, Zollikerberg, Zurich
2018-01-01
Recruiting
Swiss Rare Disease Registry (SRDR)
NCT05179863Rare Diseases
University of Bern
Observational
500,000
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2018-01-01
Active, closed
Amgen
Phase 1
269
Lausanne, Sankt Gallen
2017-12-26
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Sankt Gallen
2017-12-16
Recruiting
AbbVie
Observational
500
Aarau, Thun, Lucerne, Neuchâtel, Sankt Gallen, Winterthur, Bellinzona, Münsterlingen
2017-12-04
Active, closed
Institute of Cancer Research, United Kingdom
Phase 2/3
113
Bellinzona, Geneva, Sankt Gallen, Zurich
2017-11-27
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2017-09-12
Active, closed
University Hospital Muenster
Phase 3
650
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2017-08-03
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Bellinzona, Basel, Chur, Sankt Gallen, Zurich
2017-07-21
Recruiting
Database for the Assessment of Efficacy and Safety of BPH Treatment
NCT03521648Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Dominik Abt
Observational
500
Sankt Gallen
2017-07-07
Recruiting
Swiss Paediatric Airway Cohort
NCT03505216Asthma, Wheezing, Cough, Exercise Induced Bronchospasm
University of Bern
Observational
6,000
Aarau, Basel, Bern, Chur, Horgen, Lausanne, Lucerne, Sankt Gallen
2017-06-06
Recruiting
Diagnosis of Tuberculosis in Swiss Children
NCT03044509Tuberculosis, Mycobacterium Tuberculosis
University Children's Hospital Basel
Observational
190
Aarau, Basel, Bellinzona, Bern, Geneva, Lucerne, Sankt Gallen, Zurich
2017-05-12
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Aarau, Sankt Gallen, Zurich
2017-05-03
Active, closed
AbbVie
Phase 3
950
Basel Town, Sankt Gallen, Zurich, Bern
2017-01-31
Active, closed
University of Birmingham
Phase 3
700
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen
2016-04
Active, closed
Geron Corporation
Phase 2/3
289
Basel, Bern, Sankt Gallen, Zurich
2016-01-12
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Bellinzona, Sankt Gallen, Zurich
2015-10
Recruiting
University Hospital, Geneva
Observational
20,000
Geneva, Lausanne, Sankt Gallen, Zurich
2015-06-01
By invitation
Juvenile Inflammatory Rheumatism (JIR) Cohorte
NCT02377245Arthritis, Juvenile Rheumatoid
Michaël Hofer
Observational
15,000
Lausanne, Aarau, Basel, Bellinzona, Chur, Lucerne, Lugano, Sankt Gallen
2014-01
Recruiting
Dr. med. Christian Rothermundt
Observational
6,900
Sankt Gallen
2013-12
Recruiting
Swiss National Registry of Adults With Congenital Heart Disease
NCT02258724Congenital Heart Disease, Congenital Heart Defect
University Hospital, Basel, Switzerland
Observational
5,000
Basel, Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2013-09
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Not applicable
540
Bellinzona, Bern, Olten, Sankt Gallen
2012-10
Recruiting
Swiss Multiple Sclerosis Cohort-Study
NCT02433028Multiple Sclerosis
University Hospital, Basel, Switzerland
Observational
1,200
Aarau, Basel, Bern, Geneva, Sankt Gallen, Lausanne, Lugano, Zurich
2012-06
Recruiting
University Hospital, Basel, Switzerland
Observational
50
Sankt Gallen, Paradiso
2011-11
Recruiting
Swiss Dermatology Network for Targeted Therapies
Observational
1,121
Aarau, Basel, Bern, Lausanne, Sankt Gallen, Zurich
2011-02
Active, closed
Clinical Outcomes of Rectopexy for Rectal Prolapse
NCT07848308Rectal Prolapse, Fecal Incontinence, Rectopexy, Obstructive Defecation Syndrome
Lukas Marti
Observational
400
Sankt Gallen
2011-01-01
Recruiting
Swiss Diabetes Registry - SwissDiab Study
NCT01179815Diabetes Mellitus
Insel Gruppe AG, University Hospital Bern
Observational
1,500
Bern, Lausanne, Sankt Gallen, Zurich
2010-01
Recruiting
Swiss Study on Subarachnoid Hemorrhage
NCT03245866Subarachnoid Hemorrhage, Intracranial Aneurysm
University Hospital, Geneva
Observational
5,000
Aarau, Geneva, Sankt Gallen, Basel, Bern, Lausanne, Lucerne, Lugano
2009-01-01
Active, closed
Medical Research Council
Phase 2/3
11,992
Lausanne, Winterthur, Chur, Aarau, Basel, Bern, Liestal, Sankt Gallen
2005-07-08
Recruiting
Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
NCT04776824Amyloid Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
300
Basel, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen, Zurich
2001-02-22
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Basel, Bern, Geneva, Lausanne, Sankt Gallen, Zurich
1994-01
Rows per page Showing 1–272 of 272
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swiss investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-switzerland/city/sankt-gallen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Switzerland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,249 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 272 of those studies with a site in Sankt Gallen.

How many clinical trials are recruiting in Sankt Gallen?

156 of the 272 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 7 have not yet opened recruitment, 103 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sankt Gallen), 272 studies
PhaseStudiesRecruitingShare
Phase 3933934.2%
Observational584321.3%
Not applicable402714.7%
Phase 2392014.3%
Phase 113104.8%
Phase 2/31384.8%
Phase 1/2842.9%
Phase 4852.9%

Most active sponsors

Lead sponsors with the most studies (Sankt Gallen)
Lead sponsorStudiesRecruiting
University Hospital, Basel, Switzerland1711
Merck Sharp & Dohme LLC158
Amgen125
Insel Gruppe AG, University Hospital Bern119
Bristol-Myers Squibb107
Swiss Cancer Institute108
Janssen Research & Development, LLC93
AbbVie71
AstraZeneca53
Cantonal Hospital of St. Gallen54
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.